1. Home
  2. NBIX vs CHKP Comparison

NBIX vs CHKP Comparison

Compare NBIX & CHKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$174.19

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Check Point Software Technologies Ltd.

CHKP

Check Point Software Technologies Ltd.

HOLD

Current Price

$138.14

Market Cap

13.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
CHKP
Founded
1992
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.7B
IPO Year
1996
1997

Fundamental Metrics

Financial Performance
Metric
NBIX
CHKP
Price
$174.19
$138.14
Analyst Decision
Strong Buy
Buy
Analyst Count
22
20
Target Price
$180.91
$199.50
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$8.31
Revenue Next Year
$13.14
$6.03
P/E Ratio
$91.24
$17.05
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$112.23
52 Week High
$174.38
$225.23

Technical Indicators

Market Signals
Indicator
NBIX
CHKP
Relative Strength Index (RSI) 67.99 64.96
Support Level $153.96 $134.13
Resistance Level N/A $141.31
Average True Range (ATR) 4.48 4.71
MACD 0.66 1.70
Stochastic Oscillator 95.56 94.15

Price Performance

Historical Comparison
NBIX
CHKP

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About CHKP Check Point Software Technologies Ltd.

Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.

Share on Social Networks: